Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 11.34% |
| 3 | Financials | 9.38% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Euronet Worldwide
EEFT
$2.78B
| $21.3M | ﹤0.01% |
280,611
-21,900
| -7% | -$2.05M |
|
2127
Gold Fields
GFI
$35.4B
| $21.2M | ﹤0.01% |
2,626,147
+1,372,037
| +109% | +$11.8M |
|
2128
Vista Energy
VIST
$7.33B
| $21.2M | ﹤0.01% |
2,252,492
+318,246
| +16% | +$2.74M |
|
2129
Cricut
CRCT
$1.24B
| $21.2M | ﹤0.01% |
2,286,964
+451,996
| +25% | +$3.31M |
|
2130
AdvisorShares Pure US Cannabis ETF
MSOS
$934M
| $21.2M | ﹤0.01% |
2,376,137
-355,272
| -13% | -$4.1M |
|
|
DEN
2131
DELISTED
Denbury Inc.
DEN
| $21.2M | ﹤0.01% |
245,340
+117,811
| +92% | +$9.03M |
|
2132
Coca-Cola Femsa
KOF
$22.9B
| $21.1M | ﹤0.01% |
361,771
+66,721
| +23% | +$3.98M |
|
2133
CONMED
CNMD
$1.49B
| $21.1M | ﹤0.01% |
263,095
+34,599
| +15% | +$3.26M |
|
2134
Nuveen ESG Mid-Cap Value ETF
NUMV
$461M
| $21.1M | ﹤0.01% |
742,972
+38,058
| +5% | +$1.22M |
|
|
DPG
2135
Duff & Phelps Utility and Infrastructure Fund
DPG
$531M
| $21.1M | ﹤0.01% |
1,646,199
+49,444
| +3% | +$707K |
|
2136
Hope Bancorp
HOPE
$1.85B
| $21M | ﹤0.01% |
1,663,360
+48,475
| +3% | +$701K |
|
2137
Hancock Whitney
HWC
$6.37B
| $21M | ﹤0.01% |
458,053
-70,210
| -13% | -$3.38M |
|
2138
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.6B
| $20.9M | ﹤0.01% |
614,540
+158,810
| +35% | +$6.01M |
|
2139
Denali Therapeutics
DNLI
$3.97B
| $20.9M | ﹤0.01% |
681,332
+258,321
| +61% | +$8.4M |
|
2140
First Trust Small Cap Value AlphaDEX Fund
FYT
$202M
| $20.9M | ﹤0.01% |
515,890
+55,341
| +12% | +$2.56M |
|
2141
Resideo Technologies
REZI
$3.1B
| $20.9M | ﹤0.01% |
1,096,132
-118,565
| -10% | -$2.51M |
|
2142
WisdomTree US MidCap Fund
EZM
$960M
| $20.9M | ﹤0.01% |
474,123
-122,033
| -20% | -$5.94M |
|
|
ONEM
2143
DELISTED
1Life Healthcare
ONEM
| $20.8M | ﹤0.01% |
1,215,220
+630,732
| +108% | +$9.9M |
|
2144
ITT
ITT
$19.4B
| $20.8M | ﹤0.01% |
318,782
-30,782
| -9% | -$2.24M |
|
2145
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.8B
| $20.8M | ﹤0.01% |
431,690
+172,454
| +67% | +$9.18M |
|
2146
Cohen & Steers Duration Preferred & Income Fund
LDP
$601M
| $20.8M | ﹤0.01% |
1,148,935
-83,537
| -7% | -$1.69M |
|
2147
Erie Indemnity
ERIE
$13.4B
| $20.8M | ﹤0.01% |
93,456
-6,398
| -6% | -$1.35M |
|
2148
Inspire Medical Systems
INSP
$1.68B
| $20.8M | ﹤0.01% |
117,063
-32,817
| -22% | -$6.59M |
|
2149
John Wiley & Sons Class A
WLY
$2.63B
| $20.8M | ﹤0.01% |
552,783
+51,108
| +10% | +$2.43M |
|
2150
Chord Energy
CHRD
$7.35B
| $20.7M | ﹤0.01% |
151,651
+70,963
| +88% | +$9.1M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.